|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 14-11-03 | Covance : Dow, S&P 500 close slightly lower; semis boost Nasdaq | RE |
| 14-11-03 | Covance : LabCorp to pay $6.1 billion for drug trial company Covance | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
| Corporate Officer/Principal | - | 2023-03-05 | |
Hong Gang Bi
PRN | Corporate Officer/Principal | 67 | 2011-05-30 |
Stephen Street
PRN | Corporate Officer/Principal | 65 | 2012-06-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Glenn Eisenberg
BRD | Director/Board Member | 64 | 2015-02-18 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.49% | -3.76% | +50.31% | +62.10% | 65.42B | ||
| -0.63% | -2.91% | +6.20% | +89.22% | 58.91B | ||
| -2.37% | -2.22% | +22.87% | +82.31% | 55.24B | ||
| -2.19% | -6.15% | +11.92% | +108.08% | 45.66B | ||
| -1.89% | -7.28% | +13.22% | +19.74% | 41.29B | ||
| -0.93% | -0.47% | +19.73% | +43.75% | 36.82B | ||
| +1.11% | -6.44% | +130.68% | +641.83% | 34.48B | ||
| -0.80% | -1.73% | +75.29% | +56.47% | 32.5B | ||
| -2.17% | +16.65% | -29.21% | +474.05% | 31.69B | ||
| Average | -1.37% | -1.12% | +33.45% | +175.28% | 45B | |
| Weighted average by Cap. | -1.49% | -1.64% | +31.75% | +149.79% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















